CF Industries posts a record $615M quarter — and a war, a lawsuit, and cheap gas did most of the lifting

---

On May 6, 2026, CF Industries Holdings reported a first quarter that, read off the top line, looks like vindication for everyone who has ever argued that a low-cost nitrogen producer sitting on cheap American shale gas is a structurally advantaged machine. Net sales of $1.99 billion, up roughly 19% from $1.66 billion a year earlier. Net earnings attributable to common stockholders of $615 million, or $3.98 per diluted share — a figure that beat the consensus estimate by a margin wide enough to be embarrassing for the analysts who set it. EBITDA of $1.01 billion. Adjusted EBITDA of $983 million, nearly double the prior-year quarter. Gross ammonia production of approximately 2.5 million tons, representing 99% utilization of available capacity. By every metric a fertilizer investor tracks, CF ran its plants flat out into the best price environment in years and printed money.

The market noticed. The stock has been one of the strongest performers in the S&P 500 materials complex this year, and the Q1 print did nothing to dampen the enthusiasm. The bull thesis writes itself: nitrogen is in structural shortage, CF owns some of the lowest-cost production capacity on the planet, the company is leaning into low-carbon ammonia, and it is returning cash hand over fist. That story is not wrong. It is, in fact, partly true — which is exactly what makes it dangerous. A thesis that is partly true at the top of a cycle is the most expensive kind of thesis there is, because it gives you permission to extrapolate the part that is cyclical as though it were the part that is permanent. This is a forensic look at which is which.

Three tailwinds, one income statement, and none of them are management

Start with the bridge CF itself provided. The company attributed the year-over-year improvement in adjusted EBITDA to a small number of moving parts, and management was unusually explicit about them. Higher average selling prices across all segments contributed approximately $401 million to the EBITDA increase. Lower or higher sales volume actually subtracted about $39 million — that is, CF sold less product by volume than a year ago, not more. Realized natural gas costs were a $76 million headwind, because gas rose to $4.57 per MMBtu from $3.68 a year earlier. And folded into the adjusted figure is a roughly $170 million gain from a litigation settlement with Orica and Nelson Brothers.

Sit with that arithmetic for a moment, because it is the whole story. The dominant driver of the best quarter in years was price — $401 million of it — and price is the one variable CF does not set. Nitrogen is a global commodity priced at the margin by the highest-cost producer who must run to meet demand. When Iran-related supply disruptions tightened an already-tight market, the marginal ton got more expensive, and CF, sitting comfortably inside the first quartile of the global cost curve, captured the entire spread as windfall. That is wonderful. It is also, definitionally, not durable. CF did not engineer the shortage. It did not negotiate the price. It stood in the right place on the cost curve when a geopolitical event removed supply, and the math did the rest. The same math runs in reverse when the supply comes back.

The $401 million the company didn't earn so much as receive

This is the commodity-price-taker frame, and it is the load-bearing wall of any honest CF analysis. A price-taker has no pricing power in the economist's sense — it accepts whatever the global clearing price is and optimizes only its own cost and volume. CF is a price-taker twice over: it takes the price of natural gas on the input side and the price of ammonia, urea, and UAN on the output side. In a normal quarter those two prices move loosely together, because gas is a major cost input for the marginal global nitrogen producer, and the spread between them — the "nitrogen-to-gas spread" — is the real economic engine of the business.

What made Q1 2026 extraordinary is that the spread blew out in CF's favor for reasons unconnected to American gas. European producers, who buy gas at multiples of the Henry Hub price, and Middle Eastern producers exposed to the Iran conflict set the global price. CF buys gas at $4.57. The gap between what CF pays for energy and what the world pays for the resulting nitrogen is the entire game, and in Q1 that gap was abnormally wide. The $401 million price contribution is, in plain terms, the monetized value of someone else's energy crisis and someone else's war. It belongs in the income statement. It does not belong in a discounted-cash-flow model as a perpetuity.

The settlement that pretends to be operating income

Now the quality-of-earnings problem, and it is a real one. Adjusted EBITDA of $983 million includes approximately $170 million from a litigation settlement with Orica and Nelson Brothers. A litigation settlement is not nitrogen. It is a non-recurring legal recovery that happened to land in the quarter, and CF — like most companies — left it inside the adjusted figure rather than stripping it out as the one-time item it plainly is. Do the subtraction yourself: $983 million of adjusted EBITDA less roughly $170 million of settlement gain is closer to $813 million of operating adjusted EBITDA. Still an excellent number. But it is more than 17% lower than the figure the headline invites you to capitalize, and it is the difference between a quarter that nearly doubled year over year and one that grew at a far more pedestrian rate once you remove the courtroom and keep only the chemistry.

This matters because of how the sell-side builds models. Adjusted EBITDA is the input to the EV/EBITDA multiple that sets the price target. If $170 million of that EBITDA is a settlement that will never recur, then every multiple applied to the headline figure is silently capitalizing a legal windfall at, say, eight or ten times — assigning $1.4 to $1.7 billion of enterprise value to a one-time check. That is the denominator illusion in reverse: not a shrinking share count flattering per-share figures, but a one-time gain flattering the very profit metric the whole valuation hangs on. The honest analyst backs it out. The bullish one leaves it in and calls it conservatism.

Volume fell. Read that sentence again

Here is the detail buried under the celebration: volume subtracted roughly $39 million from EBITDA year over year. CF did not sell more fertilizer. It ran at 99% utilization — meaning the plants were already maxed last year too — and the modest volume decline tells you something the price story obscures. This is not a growth company that expanded output into rising demand. It is a fixed-capacity asset base that sold a slightly smaller pile of product into a much higher price. All of the upside, every dollar of it, came from price and a lawsuit. None came from selling more.

That is the signature of a cyclical at or near peak. A genuine growth story shows volume and price both rising as the company takes share and expands capacity. A late-cycle commodity print shows flat-to-falling volume, maxed utilization, and a price spike doing all the work. CF's Q1 is textbook late-cycle. The company cannot grow volume meaningfully without new plants, and new plants — like the Blue Point ammonia project — take years to build and arrive precisely when the cycle has a habit of turning. You are not buying a company that will sell more; you are buying one that sold the same amount for more, and praying the "more" holds.

Priced as a secular winner, structured as a cyclical

Watch how the market is treating this. CF has been among the best-performing materials names in the index, and the multiple has expanded as investors increasingly frame nitrogen as a structurally short, energy-transition-adjacent growth market rather than the violently cyclical commodity it has always been. The pitch leans on low-carbon ammonia, on data-center and clean-fuel demand narratives, on "tight through 2027" supply commentary. Each of those has a kernel of truth. But the framing performs a sleight of hand: it takes a business whose earnings just doubled because of a war and a gas-cost gap and asks you to pay a secular-growth multiple for cyclical-peak earnings.

The asymmetry here is the whole risk. When a cyclical is priced for perfection at the top of its cycle, the downside is not symmetric with the upside. If nitrogen prices hold, you make a modest return because much of the good news is in the price. If the Iran disruption resolves, if European gas normalizes, if Chinese urea export quotas loosen, the marginal ton gets cheaper and CF's $401 million price tailwind deflates — and the multiple compresses at the same time the earnings fall. That is the double-hit that defines cyclical-priced-as-secular: the E falls and the P/E falls together, and the stock does not give back the gain linearly. It gives it back in a gap.

The moat is real, but it's a loophole, not a fortress

Be precise about what CF's advantage actually is, because here the bulls deserve their due and the bears need discipline. CF's edge is geographic and geological: it operates large-scale nitrogen plants on the North American gas grid, buying feedstock at Henry Hub-linked prices that are structurally below what European and much of Asian production pays. That is a genuine, durable cost advantage on the input side. It is not a moat in the Buffett sense — there is no brand, no switching cost, no network effect, and a ton of CF urea is identical to a ton of anyone else's urea. It is a cost-curve position, which is the commodity-world version of an advantage: real, valuable, but entirely dependent on the persistence of cheap North American gas relative to the rest of the world.

The distinction matters because cost-curve advantages are loopholes that can close. They close when rivals build new low-cost capacity. They narrow when the global gas market converges — and the entire thrust of LNG export expansion is to converge regional gas prices over time, raising Henry Hub toward the global level and eroding precisely the gap CF monetizes. A moat protects you regardless of price. A loophole protects you only as long as the structural mispricing of your input persists. CF has a loophole worth owning, but the investor who calls it a fortress is going to be surprised by how fast it can shrink.

Capital returns are a function of the cycle, not a commitment

CF returns cash aggressively, and the buyback is central to the bull case. But look at the quarter's actual capital actions: the company repurchased only about 155,000 shares for roughly $15 million in Q1, leaving $1.7 billion remaining under authorization. That is a strikingly small repurchase for a quarter that generated $615 million of net earnings — which tells you management itself may be reading the cycle. When a company sits on a large authorization and barely uses it during a record quarter, one reasonable interpretation is that the people closest to the gas-to-nitrogen spread are not convinced the price is permanent either, and are husbanding cash rather than buying their own stock at an elevated multiple.

Meanwhile capital expenditure guidance for 2026 is approximately $1.3 billion consolidated, with several hundred million earmarked for the Blue Point joint venture and growth infrastructure. The buyback that the bull case capitalizes is the residual after sustaining capex and growth capex — and that residual is feast-or-famine with the cycle. In a peak year there is plenty to return; in a trough year, when nitrogen prices halve and gas spikes, the free cash flow that funds buybacks evaporates while the capex commitments do not. Capital returns from a commodity producer are not a policy. They are a weather report.

The 2027 promise depends on the war not ending

CF's own forward commentary leans heavily on a "tight through 2027" global nitrogen outlook, noting that a large share of first-quartile global urea capacity is exposed to geopolitical conflict. Parse the logic honestly: the bull case for sustained high prices is, substantially, a bet that geopolitical supply disruption persists. That is an unusual thing to underwrite. It means the investor is implicitly long a continued conflict near a major energy and fertilizer-producing region — long disruption, long scarcity, long the very instability that lifted the marginal price in Q1.

Disruptions resolve. Quotas change. Idled capacity restarts the moment prices justify it, because that is what high prices do in a commodity — they call forth supply. The "tight through 2027" thesis is not a forecast of CF's execution; it is a forecast of geopolitics, and geopolitics is the one input even more unpredictable than natural gas. When the company's best argument for durable earnings is a map of conflict zones rather than a chart of its own capacity additions, you are no longer analyzing a business. You are handicapping a war, and pricing the stock as though your handicap is certain.

What the bulls genuinely get right

This is where honesty is non-negotiable, because the bull case on CF is far stronger than a pure short thesis would like it to be, and pretending otherwise would be its own form of dishonesty.

First, the cost advantage is real and it is durable on any horizon that matters to a normal investor. CF buys North American gas at $4.57 per MMBtu while large swaths of global competition pay multiples of that. Even if LNG exports converge regional prices over a decade, that convergence is slow, and for years to come CF will sit comfortably in the first quartile of the global nitrogen cost curve. That is not a trick. It is a structural fact of where the assets sit, and it means CF makes money in price environments where higher-cost producers bleed. In a trough, CF survives and consolidates while marginal producers idle. That is genuine resilience.

Second, the demand story has real legs that have nothing to do with the war. Nitrogen demand is anchored to global agriculture and food security, which grow slowly but relentlessly. And the low-carbon and clean-ammonia opportunity — ammonia as a hydrogen carrier and marine fuel, blue ammonia with carbon capture — is a credible, multi-decade optionality that CF is investing in ahead of peers. If even a fraction of the clean-ammonia demand thesis materializes, CF has first-mover scale.

Third, the balance sheet and cash generation are legitimately strong. Trailing-twelve-month operating cash flow around $2.66 billion and free cash flow around $1.65 billion give the company real flexibility to fund growth, sustain the dividend, and buy back stock opportunistically. Management's restraint on the Q1 buyback is arguably a sign of discipline, not weakness. A company that generates this much cash, sits this low on the cost curve, and is investing in a credible long-term demand vector is not a house of cards. The bear case is not "CF is bad." It is "CF is cyclical, and you are paying a peak price for peak earnings inflated by a one-time settlement." Those are very different claims, and only the second is defensible.

The quality-of-utilization tell

One more forensic detail worth surfacing. Ammonia production at 99% of available capacity is presented as an achievement, and operationally it is — CF runs its plants exceptionally well. But 99% utilization is also a ceiling, not a runway. A company already running flat out has exactly one lever left for growth: price. It cannot make the quarter better by making more. This is why the volume line went negative even in a banner quarter — there was simply no more capacity to flex. For an investor, near-100% utilization at peak prices is the clearest possible signal that the easy gains are behind, not ahead. The next leg of growth requires Blue Point and other multi-year projects to come online, and those arrive on their own schedule, indifferent to where the cycle is when they do.

The kicker

CF Industries did everything right in the first quarter of 2026, and almost none of it was in its control. It ran its plants at 99%, captured a global price spike it did not create, banked a $170 million legal settlement it will not repeat, and paid for energy at a fraction of the world price thanks to a gas-cost gap that LNG exports are slowly working to close. The result is a genuinely excellent business reporting genuinely cyclical-peak earnings, and a market increasingly tempted to capitalize those earnings as though a war, a lawsuit, and cheap shale gas are permanent fixtures of the model rather than the three transient gifts they actually were. None of that makes CF a bad company. It makes the stock an expensive way to be long a set of conditions that, by their nature, end.

The danger was never that CF Industries can't make money — it obviously can, and the cost-curve position is real; the danger is that the best quarter in years was built almost entirely on a price spike it didn't engineer, a settlement it won't repeat, and a gas-cost gap the rest of the world is racing to close, and the market is now pricing all three as permanent right at the moment each one is most likely to fade.